Evidence map›Paper›PMID 41696656›Full record

ArticleEnvironmental epidemiology (Philadelphia, Pa.)2026

Prenatal exposure to per- and polyfluoroalkyl substances and risk of autism spectrum disorder in the California Central Valley, 2004-2010.

Katherine Osborne, Zeyan Liew, Xin Cui, Douglas I Walker, Dean P Jones, YuYuan Lin, Karl O'Sharkey, Julia E Heck, Kimberly C Paul, Beate Ritz

Abstract read
In one paragraph

Article in Environmental epidemiology (Philadelphia, Pa.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Katherine OsborneDepartment of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California.ORCID https://orcid.org/0009-0007-4228-037X
Zeyan LiewDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut.
Xin CuiPerinatal Epidemiology and Health Outcomes Research Unit, Division of Neonatology, Department of Pediatrics, Stanford University School of Medicine and Lucile Packard Children's Hospital, Palo Alto, California.
Douglas I WalkerGangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Dean P JonesClinical Biomarkers Laboratory, Division of Pulmonary, Allergy, and Critical Care Medicine, School of Medicine, Emory University, Atlanta, Georgia.
YuYuan LinDepartment of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California.
Karl O'SharkeyDepartment of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California.
Julia E HeckDepartment of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California.
Kimberly C PaulDepartment of Neurology, UCLA School of Medicine, Los Angeles, California.
Beate RitzDepartment of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California.ORCID https://orcid.org/0000-0001-6976-7339

Funding

Autism Metabolomics and Environment (AIME)R21ES025573 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RITZ, BEATE R. · 2015 to 2016
$436k
NIEHS NIH HHS R21 ES025573
6 · The paper itself

Abstract

Background: There is mixed evidence regarding the association between per- and polyfluoroalkyl substances (PFAS) and autism spectrum disorder (ASD). Methods: We matched 294 ASD cases to 286 controls by sex, birth year, and exposure to selected pesticides and air pollution. All participants were born in the California Central Valley from 2004 to 2010. Using high-resolution metabolomic profiling, three PFAS were measured in >60% of maternal serum samples: perfluorooctanoic acid (PFOA), perfluorohexanesulfonic acid, and perfluorooctane sulfonate (PFOS). Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were estimated using logistic regression to examine relationships between PFAS and ASD. Nonlinear associations were examined using restricted cubic spline regression, and a quantile-based g-computation approach was utilized to examine the association between a PFAS mixture and ASD. Results: We found an elevated aOR for ASD comparing the highest to the lowest PFOA exposure quartile (aOR = 1.71; 95% CI = 0.96, 3.06); this was not seen with perfluorohexanesulfonic acid or PFOS. We saw a Conclusions: We found that prenatal exposure to PFOA was associated with ASD in children, particularly among mothers with lower education levels. Larger studies are warranted to replicate our findings.

Indexed as

Autism spectrum disorderPolyfluoroalkyl substances

Identifiers

PMID41696656
PMCPMC12900219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.